Qiu, Y., Jacobs, D. M., Messer, K., Salmon, D. P., Wellington, C. L., Stukas, S., . . . Group, T. A. D. C. S. T. P. A. S. Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease. BMC.
Chicago Style (17th ed.) CitationQiu, Yuqi, et al. Prognostic Value of Plasma Biomarkers for Informing Clinical Trial Design in Mild-to-moderate Alzheimer’s Disease. BMC.
MLA (9th ed.) CitationQiu, Yuqi, et al. Prognostic Value of Plasma Biomarkers for Informing Clinical Trial Design in Mild-to-moderate Alzheimer’s Disease. BMC.
Warning: These citations may not always be 100% accurate.